• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/40

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

40 Cards in this Set

  • Front
  • Back
Most common category of ovarian primary tumors is ___
- epithelial tumors (60% of all ovarian tumors belong to this category)
- 90% of malignant ovarian tumors belong to this category
- serous and mucinous make up half of the epithelial ovariant tumors

- three main categories: epithelial, sex cord-stromal, and germ cell
- other: soft tissue tumors, lymphomas, metastases
most common malignant sex cord-stromal tumor of the ovary is __
- granulosa cell tumor
The single most common ovarian tumor is ___
- benign cystic teratoma (germ cell tumor) 32% of ovarian tumors
sex cord-stromal tumors make up __% of ovarian tumors
9%
Epithelial ovarian tumors are classified as mixed when at least __% of the second pattern is present
10% or more
Ovarian cancer rarely occurs during pregnancy, but when it does, it is most likely to be ___ or __
- serous or mucinous carcinoma
Ovarian tumors and ascites
- ascites rarely occurs with a benign tumor
- it is suggestive of carcinoma
CA-125 can be elevated in benign conditions such as ___
- endometriosis
- pregnancy
- PID
- leiomyomas
- liver disease
micropapillary borderline serous tumors are associated with __
- high likelihood of extraovarian spread and invasive implants
- corrected for stage and implant type, there is no difference in survival compared to typical borderline serous tumor
Restaging after inadequate staging of ovariant borderline serous tumors?
- controversial
- 15% the stage is altered
- risk of recurrence appears the same for women undergoing restaging vs. those that do not

- may be more indicated if micropapillary borderline serous tumor (higher risk of having extraovarian spread and invasive implants)
FIGO staging for ovarian cancer
I - confined to ovaries
II - pelvic extension/implants
III - extension outside pelvis
IV - distant metastasis
FIGO stage IA-B for ovarian cancer
IA - tumor limited to ONE ovary (A ovary), intact capsule, no surface tumor, negative cytology

IB - tumor limited to Both ovaries, intact capsule, no surface tumor, negative cytology

IC - limit to one or both ovaries with any of the following: capsule rupture, surface tumor, positive cytology
Does the size of the peritoneal metastases matter in ovarian cancer?
Yes
- peritoneal metastases (mets beyond pelvis)= FIGO stage III
IIIA - microscopic mets
IIIB - macroscopic, but </= 2 cm
IIIC - macroscopic, but > 2cm and/or lymph node mets
serous tumors make up __% of ovariant tumors
- 30% of ovarian tumors
- 50% are benign, 15% borderline, and 35% malignant
__% of benign serous tumors are bilateral
20%
__% of serous cystadenomas are actually monoclonal
- 14%
A otherwise benign appearing serous cystadenoma or cystadenofibroma with focal borderline features?
- <5-10% of the tumor shows borderline features (mild to moderate nuclear atypia or branching papillary growth)

- serous cystadenoma, cystadenofibroma, or adenofibroma with focal low grade aytpia or proliferation

- requires further study
Serous tumors: bilaterality
- benign (20%)
- borderline (35-40%)
- malignant (often bilateral)
serous borderline tumors, surface papillary excrescences are present in __
40-50%
serous borderline tumor, solid growth is __
- uncommon (exception: borderline serous adenofibroma)
- necrosis and hemorrhage are also uncommon
Papillary growth pattern in serous borderline tumors is __
- branching (hierarchical)
- fibrovascular cores lined by proliferating columnar cells
- may see cilia
- tufts of cells leading to clusters and single cells detached into cyst lumen
In serous borderline tumors, the nuclear atypia is typically __
- low grade nuclear atypia
- scattered mitotic figures
Serous borderline tumors - see scattered indifferent cells
- aka metaplastic cells
- cells with abundant eosinophilic cytoplasm
- scattered among the columnar tumor cells, more often near tips of papillae
- indifferent cells are more common in cases with microinvasion and in pregnancy
Autoimplants in serous borderline tumors
- resemble desomplastic peritoneal implants, but occur within the tumor cyst wall
- plaque or nodule of loose fibrous tissue with glands and/or papillae
- no prognostic significance!!, but more often seen in high stage tumors
Wall thickness in benign cystadenoma vs borderline cystadenoma
benign - thin wall
borderline - thicker wall
microinvasion in serous borderline tumors (two types)
- invasive foci < 3mm
- when present it is often multifocal (when do you just call it invasive carcinoma??)

Two types:
1. (most common) - see cells with eosinophilic cytoplasm, vesicular nuclei, prominent nucleoli
- no stromal reaction
- occasionally seen in lymphatic spaces with uncertain clinical significance

2. tumor cells surrounded by stroml response (inflamed or myxoid fibrous stroma) or cells within clear spaces
Serous borderline tumor wit implants
- 15-30% cases have implants

3 types
- non-invasive epithelial type
- non-invasive desmplastic type
- invasive type
Most significant adverse prognostic findings in serous borderline tumors
- presence or absence of invasive implants AND advanced tumor stage

- non-invasive implants (epithelial and desmoplastic, are a/w favorable prognsosis)
invasive vs desmoplastic implants
- there is more epithelium present in the invasive implant compared to desmoplastic implants
- plus invasive implants show an infiltrative pattern of growth into surrounding subperitoneal tissues and omentum
Lymph node metastases are seen in __% of serous borderline tumors
up to 33%
__ may mimic lymph node involvement by serous borderline tumor
1. Mesothelial cell hyerplasia
- uncommon
- hyperplastic mesothelial cells
- a/w peritoneal mesothelial hyperplasia
- cells would be positive for calretinin, CK5/6

2. Benign epithelial inclusions (endosalpingiosis)
- lined by low columnar cells, many w/ cilia
- seen in pelvic and peri-aoritc LN in 5-25% pts undergoing surgery for UTERINE cancers
- controversy: some believe them to rep lymph node involvement by serous borderline tumor, while others disagree and believe them to be benign inclusions
clinical significance of lymph node involvement by serous borderline tumor
- believed NOT be a/w with adverse outcome
- However, recently suggested the tumor aggregates > 1mm may be a/w decreased survival
the papillae seen in serous borderline tumor with micropapillary features
- many are long, thin micropapillae and lack fibrovascular cores
- these micropapillae sprout from the surface of coarse papillary fronds
- micropapillae are 5 times as long as they are wide
- ciliated cells are less frequent than in typical borderline tumors
serous borderline tumor with micropapillary features are a/w ___
- bilaterality
- intracystic and surface papillary growth
- extraovarian disease
- invasive implants (in some studies)
In order to qualify for serous borderline tumor with micropapillary features the focus of micropapillary architecture must be greater than __
0.5 cm or more
Serous surface papillary carcinoma of the ovary vs. primary peritoneal serous carcinoma with involvement of the ovaries
- serous surface papillary carcinoma show predominantly surface growth with minimal parenchymal invasion and NO intracystic growth

Primary peritoneal serous carcinoma with ovarian involvement:
- extensive peritoneal serous carcinoma
- FOCAL (</= 0.5cm) of ovariant surface tumor present
Why do "they" think most ovarian serous carcinomas start out as high grade tumors
- a limited number of microscopic serous carcinomas have been reported
- most serous caricnomas are high grade tumors with marker cytologic atypia and frequent mitotic figures

- low grade serous carcinomas are "different" tumors, appear to arise from progression of serous borderline tumors
IHC for ovarian serous carcinoma
CK7+ CK20=
p53+
WT-1+ (endometrioid serous carcinomas are WT-1=)
CA-125+

Vimentin=
CEA=
CDX-2=


Clear cell carcinoma:
WT-1=
CA-125=
Low grade serous carcinoma of the ovary
- uncommon
- may be mixed with areas of borderline tumor
- appear to have a DIFFERENT histogenesis from high grade tumors
- some or all may arise by progression of serous borderline tumors
Universal grading system for ovarian carcinomas proposed by __
- Silverberg et al